UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer

World journal of urology, 2018-12, Vol.36 (12), p.1981-1995

2018

Volltextzugriff (PDF)

Management of bladder cancer in older patients: Position paper of a SIOG Task Force

Journal of geriatric oncology, 2020-09, Vol.11 (7), p.1043-1053

2020

Volltextzugriff (PDF)

Erratum zu: Lokal fortgeschrittene oder oligometastasierte Blasenkarzinome – Stellenwert der Lokaltherapie von Primärtumor und Metastasen

Urologie (Heidelberg, Germany), 2022-07, Vol.61 (7), p.781-781

2022

Volltextzugriff (PDF)

Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer

Molecular cancer therapeutics, 2013-07, Vol.12 (7), p.1245-1254

2013

Volltextzugriff (PDF)

Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach

PloS one, 2013-03, Vol.8 (3), p.e59536-e59536

2013

Volltextzugriff (PDF)

Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics

Translational oncology, 2015-06, Vol.8 (3), p.210-216

2015

Volltextzugriff (PDF)

Stratification of Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies

European urology focus, 2021-05, Vol.7 (3), p.566-573

2021

Volltextzugriff (PDF)

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer

BJU international, 2019-06, Vol.123 (6), p.959-967

2019

Volltextzugriff (PDF)

The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer

Urologic oncology, 2016-12, Vol.34 (12), p.533.e1-533.e10

2016

Volltextzugriff (PDF)

Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non–muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guérin: Implications for Decision-making?

European urology open science (Online), 2023-04, Vol.50, p.17-23

2023

Volltextzugriff (PDF)

CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study

Cancer Research and Treatment, 2015, 47(2), , pp.306-312

2015

Volltextzugriff (PDF)

RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease

Neoplasia (New York, N.Y.), 2009-09, Vol.11 (9), p.956-963

2009

Volltextzugriff (PDF)

The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis

European urology, 2021-06, Vol.79 (6), p.783-792

2021

Volltextzugriff (PDF)

Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma (UTUC)

Clinical genitourinary cancer, 2017-12, Vol.15 (6), p.e1039-e1045

2017

Volltextzugriff (PDF)

Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells

Oncology letters, 2017-06, Vol.13 (6), p.4085-4092

2017

Volltextzugriff (PDF)

Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer

World journal of urology, 2018-11, Vol.36 (11), p.1703-1709

2018

Volltextzugriff (PDF)

Reply to Xiaoshuai Gao, Guo Chen, and Xin Wei’s Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol 2021;79:783–92

European urology, 2021-12, Vol.80 (6), p.e145-e146

2021

Volltextzugriff (PDF)

Preoperative anemia is associated with disease recurrence and progression in patients with non–muscle-invasive bladder cancer

Urologic oncology, 2017-03, Vol.35 (3), p.113.e9-113.e14

2017

Volltextzugriff (PDF)

Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study

European urology, 2019-04, Vol.75 (4), p.695-696

2019

Volltextzugriff (PDF)

Molecular markers in bladder cancer

World journal of urology, 2019-01, Vol.37 (1), p.31-40

2019

Volltextzugriff (PDF)

Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer

Urologic oncology, 2017-06, Vol.35 (6), p.356-362

2017

Volltextzugriff (PDF)

Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser’s Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?

European urology, 2021-04, Vol.79 (4), p.e113-e114

2021

Volltextzugriff (PDF)

Surgical checklist impact on recurrence‐free survival of patients with non‐muscle‐invasive bladder cancer undergoing transurethral resection of bladder tumour

BJU international, 2019-04, Vol.123 (4), p.646-650

2019

Volltextzugriff (PDF)

Immune therapy meets precision medicine

The lancet oncology, 2017-03, Vol.18 (3), p.271-273

2017

Volltextzugriff (PDF)

Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy

Clinical cancer research, 2016-06, Vol.22 (12), p.2981-2992

2016

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(80)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(50)
Humans
(38)
Urology & Nephrology
(32)
Oncology
(29)
Urology
(25)
Male
(23)
Female
(19)
Bladder Cancer
(18)
Aged
(16)
Urinary Bladder Neoplasms - Pathology
(16)
Middle Aged
(15)
Cancer
(14)
Prognosis
(13)
Retrospective Studies
(13)
Medicine
(11)
Medicine & Public Health
(10)
Cystectomy
(9)
Treatment Outcome
(9)
Tumors
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer

Management of bladder cancer in older patients: Position paper of a SIOG Task Force

Erratum zu: Lokal fortgeschrittene oder oligometastasierte Blasenkarzinome – Stellenwert der Lokaltherapie von Primärtumor und Metastasen

Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer

Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach

Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics

Stratification of Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer

The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer

Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non–muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guérin: Implications for Decision-making?

CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study

RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease

The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis

Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma (UTUC)

Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells

Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer

Preoperative anemia is associated with disease recurrence and progression in patients with non–muscle-invasive bladder cancer

Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study

Molecular markers in bladder cancer

Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer

Surgical checklist impact on recurrence‐free survival of patients with non‐muscle‐invasive bladder cancer undergoing transurethral resection of bladder tumour

Immune therapy meets precision medicine

Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy

Suchergebnisse filtern